Author

Anja M. Richter

Berlin Institute of Health at Charité - Universitätsmedizin BerlinORCID 0000-0001-5297-3750Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Christian DrosteniD· 2 shared Daniela NiemeyeriD· 2 shared Altuna AkaliniD· 1 shared Andi KrumbholziD· 1 shared Andranik IvanoviD· 1 shared Andreas Christian HockeiD· 1 shared Asija Diag· 1 shared Barbara MühlemanniD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Christian DrostenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyProceedings of the National Academy of SciencesPeer-reviewedJul 30, 2024

Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants

Barbara Mühlemann, Jakob Trimpert, Felix Walper…·Christian Drosten

The paper uses hamster sera from variant-specific infections to map antigenic differences among SARS-CoV-2 variants, revealing significant antigenic variation among Omicron subvariants.

17 citationstop 4%

mouseexperimental assay

𝕏 PostBluesky

Systems BiologyiSciencePeer-reviewedFeb 7, 2021

Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention

Emanuel Wyler, Kirstin Mösbauer, Vedran Franke…·Markus Landthaler

The paper uses bulk and single-cell transcriptomics to analyze SARS-CoV-2 infection in human cell lines, identifying HSP90 as a potential therapeutic target.

317 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky